Michelle J. Bauer

991 total citations
37 papers, 451 citations indexed

About

Michelle J. Bauer is a scholar working on Epidemiology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Michelle J. Bauer has authored 37 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 12 papers in Molecular Medicine and 7 papers in Pharmacology. Recurrent topics in Michelle J. Bauer's work include Antibiotic Resistance in Bacteria (12 papers), Burkholderia infections and melioidosis (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Michelle J. Bauer is often cited by papers focused on Antibiotic Resistance in Bacteria (12 papers), Burkholderia infections and melioidosis (9 papers) and Antibiotics Pharmacokinetics and Efficacy (7 papers). Michelle J. Bauer collaborates with scholars based in Australia, France and Bangladesh. Michelle J. Bauer's co-authors include Sarah Shigdar, David Hammond, Patrick N. A. Harris, Joanna Macdonald, David L. Paterson, Ian Gassiep, Robert Norton, P. Bétrémieux, E. Le Gall and Michel Cormier and has published in prestigious journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Critical Care Medicine.

In The Last Decade

Michelle J. Bauer

35 papers receiving 447 citations

Peers

Countries citing papers authored by Michelle J. Bauer

Since Specialization

Citations

This map shows the geographic impact of Michelle J. Bauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michelle J. Bauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michelle J. Bauer more than expected).

Fields of papers citing papers by Michelle J. Bauer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michelle J. Bauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michelle J. Bauer. The network helps show where Michelle J. Bauer may publish in the future.

Co-authorship network of co-authors of Michelle J. Bauer

This figure shows the co-authorship network connecting the top 25 collaborators of Michelle J. Bauer. A scholar is included among the top collaborators of Michelle J. Bauer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michelle J. Bauer. Michelle J. Bauer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Securing Jugular Central Venous Catheters With Dressings Fixed to a Liquid Adhesive to Prevent Dressing Failure in Intensive Care Patients (the STICKY Trial): A Randomized Controlled Trial 2025 ·Critical Care Medicine ·(unknown), Catherine O’Brien, Emily Larsen, Evan Alexandrou, Robert S. Ware, (unknown), Fiona Coyer, (unknown), (unknown), Claire M. Rickard, Kellie Sosnowski, Patrick N. A. Harris, Kevin B. Laupland, Michelle J. Bauer, John F. Fraser, (unknown), (unknown), Amanda Corley	0
2	The complete genome sequence of five pre-2013 Escherichia coli sequence type (ST)1193 strains reveals insights into an emerging pathogen 2024 ·Access Microbiology ·(unknown), Melinda M. Ashcroft, Michelle J. Bauer, Jan Bell, (unknown), Laura Álvarez-Fraga, Justine S. Gibson, (unknown), Joanne L. Mollinger, Kate M. Peters, Minh‐Duy Phan, Leah W. Roberts, Benjamin A. Rogers, Mark A. Schembri, Darren J. Trott, John Turnidge, Brian M. Forde, Scott A. Beatson	1
3	Rapid nanopore sequencing and predictive susceptibility testing of positive blood cultures from intensive care patients with sepsis 2024 ·Microbiology Spectrum ·Patrick N. A. Harris, Michelle J. Bauer, (unknown), Stephan Beisken, Brian M. Forde, (unknown), Menino Osbert Cotta, Luregn J. Schlapbach, Sainath Raman, Kiran Shekar, Peter Krüger, Jeffrey Lipman, Seweryn Bialasiewicz, Lachlan Coin, Jason A. Roberts, David L. Paterson, Adam Irwin	15
4	Comparison of Low‐Level to High‐Level Disinfection in Eliminating Microorganisms From Ultrasound Transducers Used on Skin: A Noninferiority Randomized Controlled Trial 2023 ·Journal of Ultrasound in Medicine ·(unknown), (unknown), Michelle J. Bauer, Stacey Llewellyn, Peter J. Snelling, Nicole Marsh, Patrick N. A. Harris, Adam G. Stewart, Claire M. Rickard	3
5	In-vitro activity of oral third-generation cephalosporins plus clavulanate against ESBL-producing Enterobacterales isolates from the MERINO trial 2023 ·International Journal of Antimicrobial Agents ·Adam G. Stewart, Michelle J. Bauer, (unknown), (unknown), Andrew Henderson, Patrick N. A. Harris, David L. Paterson	4
6	Rapid molecular detection of CMY-2, and CTX-M group 1 and 9 variants via recombinase polymerase amplification 2023 ·JAC-Antimicrobial Resistance ·(unknown), Adam Irwin, Joanne Macdonald, Michelle J. Bauer, Claire Wang, Patrick N. A. Harris, Claire Heney, Hosam M. Zowawi, David M. Whiley	0
7	Melioidosis Queensland: An analysis of clinical outcomes and genomic factors 2023 ·PLoS neglected tropical diseases ·Ian Gassiep, (unknown), (unknown), Michelle J. Bauer, (unknown), Brian M. Forde, Mark D. Chatfield, Weiping Ling, Robert Norton, Patrick N. A. Harris	1
8	Evaluation of Illumina® COVIDSeq™ as a tool for Omicron SARS-CoV-2 characterisation 2023 ·Journal of Virological Methods ·Kym Lowry, Michelle J. Bauer, Cameron Buckley, Claire Wang, (unknown), Steven G. Badman, Patrick N. A. Harris, Ian M Mackay, David M. Whiley	1
9	Pharmacodynamics of Piperacillin-Tazobactam/Amikacin Combination versus Meropenem against Extended-Spectrum β-Lactamase-Producing Escherichia coli in a Hollow Fiber Infection Model 2022 ·Antimicrobial Agents and Chemotherapy ·Kamrul Islam, Fekade B. Sime, Steven C. Wallis, Michelle J. Bauer, (unknown), (unknown), Hosam M. Zowawi, M. A. Choudhury, Tahmina Shirin, (unknown), Patrick N. A. Harris, Meerjady Sabrina Flora, Jason A. Roberts	8
10	Pharmacodynamic evaluation of piperacillin/tazobactam versus meropenem against extended-spectrum β-lactamase-producing and non-producing Escherichia coli clinical isolates in a hollow-fibre infection model 2022 ·Journal of Antimicrobial Chemotherapy ·Kamrul Islam, Fekade B. Sime, Steven C. Wallis, Michelle J. Bauer, Brian M. Forde, Patrick N. A. Harris, Tahmina Shirin, (unknown), Meerjady Sabrina Flora, Jason A. Roberts	4
11	Pharmacodynamic evaluation of piperacillin/tazobactam against extended-spectrum β-lactamase (ESBL)-producing versus non-ESBL-producing Escherichia coli in a hollow-fibre infection model 2022 ·International Journal of Antimicrobial Agents ·Kamrul Islam, Fekade B. Sime, Michelle J. Bauer, Brian M. Forde, Steven C. Wallis, Patrick N. A. Harris, (unknown), Tahmina Shirin, (unknown), Meerjady Sabrina Flora, Jason A. Roberts	1
12	Comparative evaluation of Panther Fusion and real-time PCR for detection of Burkholderia pseudomallei in spiked human blood 2022 ·Access Microbiology ·Ian Gassiep, Michelle J. Bauer, Mélissa Pagé, Patrick N. A. Harris, Robert Norton	1
13	Performance of the BioFire Blood Culture Identification 2 panel for the diagnosis of bloodstream infections 2022 ·Heliyon ·Anna Maria Peri, Michelle J. Bauer, Haakon Bergh, (unknown), David L. Paterson, Patrick N. A. Harris	22
14	Optimized Method for Bacterial Nucleic Acid Extraction from Positive Blood Culture Broth for Whole-Genome Sequencing, Resistance Phenotype Prediction, and Downstream Molecular Applications 2022 ·Journal of Clinical Microbiology ·Michelle J. Bauer, Anna Maria Peri, (unknown), Stephan Beisken, Haakon Bergh, Brian M. Forde, Cameron Buckley, (unknown), (unknown), David L. Paterson, David M. Whiley, Patrick N. A. Harris	9
15	Genomic analysis of Elizabethkingia species from aquatic environments: Evidence for potential clinical transmission 2021 ·Current Research in Microbial Sciences ·Sopheak Hem, Veronica M. Jarocki, Dave Baker, Ian G. Charles, Barbara Drigo, (unknown), Erica Donner, (unknown), Michelle J. Bauer, Patrick N. A. Harris, Ethan R. Wyrsch, Steven P. Djordjevic	17
16	Laboratory safety: handling B. pseudomallei isolates without a biosafety cabinet 2021 ·Pathology ·Ian Gassiep, Michelle J. Bauer, Patrick N. A. Harris, Mark D. Chatfield, Robert Norton	1
17	Burkholderia pseudomallei Clinical Isolates Are Highly Susceptible In Vitro to Cefiderocol, a Siderophore Cephalosporin 2020 ·Antimicrobial Agents and Chemotherapy ·(unknown), Gemma Robertson, Andrew Henderson, (unknown), Michelle J. Bauer, Kyra Cottrell, Ian Gassiep, Robert Norton, David L. Paterson, Patrick N. A. Harris	16
18	Smile - Secure my intravenous line effectively: A pilot randomised controlled trial of peripheral intravenous catheter securement in paediatrics 2020 ·Journal of Tissue Viability ·Tricia Kleidon, Claire M. Rickard, Victoria Gibson, Gabor Mihala, Jessica Schults, Hui Xu, Michelle J. Bauer, Nicole Marsh, Emily Larsen, (unknown), Amanda Ullman	15
19	Central venous access device Securement and dressing effectiveness: The CASCADE pilot randomised controlled trial in the adult intensive care 2019 ·Australian Critical Care ·Marion Mitchell, Amanda Ullman, Mari Takashima, (unknown), Gabor Mihala, Madeleine Powell, Victoria Gibson, Li Zhang, Michelle J. Bauer, E. Geoffrey Playford, Claire M. Rickard	11
20	Conjugative transfer of ICESde 3396 between three β-hemolytic streptococcal species 2014 ·BMC Research Notes ·Danielle J. Smyth, (unknown), Michelle J. Bauer, (unknown), Celia L. McNeilly, Kadaba S. Sriprakash, David J. McMillan	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact